naltrexone and n-(1-carboxy-3-phenylpropyl)-alanyl-alanyl-phenylalanine-4-aminobenzoate

naltrexone has been researched along with n-(1-carboxy-3-phenylpropyl)-alanyl-alanyl-phenylalanine-4-aminobenzoate in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Costa, BR; Orlowski, M; Petrov, ES; Rice, KC; Robinson, SR; Smotherman, WP; Varlinskaya, EI1

Other Studies

1 other study(ies) available for naltrexone and n-(1-carboxy-3-phenylpropyl)-alanyl-alanyl-phenylalanine-4-aminobenzoate

ArticleYear
Central administration of the endopeptidase 24.15 inhibitor cFP-AAF-pAB suggests dynorphin as the endogenous ligand underlying behavioral effects of milk in the fetal rat.
    Pharmacology, biochemistry, and behavior, 1994, Volume: 47, Issue:3

    Topics: Amino Acid Sequence; Animals; Behavior, Animal; Cisterna Magna; Dynorphins; Female; Fetus; Injections; Ligands; Metalloendopeptidases; Milk; Molecular Sequence Data; Naltrexone; Narcotic Antagonists; Oligopeptides; Physical Stimulation; Pregnancy; Rats; Rats, Sprague-Dawley; Somatostatin

1994